Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2013 Mar 27th 2013, 00:00 BMI View: Cambodia is a market with strong growth potential for pharmaceutical firms, given the manyunmet medical needs. However, we highlight that such frontier markets are highly risky, given the lack ofproper regulation, extensive bureaucracy and rampant corruption. As a consequence, firms looking toexpand in these regions must contend with low or negative sales growth initially.Headline Expenditure Projections? Pharmaceuticals: KHR721.1bn (US$170mn) in 2012 to KHR812.5bn (US$190mn) in 2013; +12.7% inlocal currency terms and +11.2% in US dollar terms. Healthcare: KHR3262.7bn (US$780mn) in 2012to KHR3582.4bn (US$850mn) in 2013; +9.8% in local currency terms and...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions